Detection of antisperm-antibodies in patients with primary testicular cancer

Richard Foster, L. R. Rubin, A. McNulty, Richard Bihrle, J. P. Donohue

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Serum antisperm-antibodies have been noted to develop as a result of various types of testicular pathology and injury. Their presence sometimes correlates with impaired fertility. We examined 52 patients with non-seminomatous low-stage testicular cancer for the presence of serum antisperm-antibodies to determine whether or not auto-immunity is a factor in the depressed fertility known to exist in these patients. Twenty-one per cent were discovered to have serum antisperm-antibodies using an immunofluorescent technique.

Original languageEnglish
Pages (from-to)179-185
Number of pages7
JournalInternational Journal of Andrology
Volume14
Issue number3
StatePublished - 1991

Fingerprint

Testicular Neoplasms
Fertility
Antibodies
Serum
Immunity
Pathology
Wounds and Injuries

Keywords

  • antisperm-antibodies
  • immunofluorescence
  • testis cancer

ASJC Scopus subject areas

  • Endocrinology

Cite this

Detection of antisperm-antibodies in patients with primary testicular cancer. / Foster, Richard; Rubin, L. R.; McNulty, A.; Bihrle, Richard; Donohue, J. P.

In: International Journal of Andrology, Vol. 14, No. 3, 1991, p. 179-185.

Research output: Contribution to journalArticle

@article{6b8431aad760487ebd55b7664e5c726f,
title = "Detection of antisperm-antibodies in patients with primary testicular cancer",
abstract = "Serum antisperm-antibodies have been noted to develop as a result of various types of testicular pathology and injury. Their presence sometimes correlates with impaired fertility. We examined 52 patients with non-seminomatous low-stage testicular cancer for the presence of serum antisperm-antibodies to determine whether or not auto-immunity is a factor in the depressed fertility known to exist in these patients. Twenty-one per cent were discovered to have serum antisperm-antibodies using an immunofluorescent technique.",
keywords = "antisperm-antibodies, immunofluorescence, testis cancer",
author = "Richard Foster and Rubin, {L. R.} and A. McNulty and Richard Bihrle and Donohue, {J. P.}",
year = "1991",
language = "English",
volume = "14",
pages = "179--185",
journal = "International Journal of Andrology",
issn = "0105-6263",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Detection of antisperm-antibodies in patients with primary testicular cancer

AU - Foster, Richard

AU - Rubin, L. R.

AU - McNulty, A.

AU - Bihrle, Richard

AU - Donohue, J. P.

PY - 1991

Y1 - 1991

N2 - Serum antisperm-antibodies have been noted to develop as a result of various types of testicular pathology and injury. Their presence sometimes correlates with impaired fertility. We examined 52 patients with non-seminomatous low-stage testicular cancer for the presence of serum antisperm-antibodies to determine whether or not auto-immunity is a factor in the depressed fertility known to exist in these patients. Twenty-one per cent were discovered to have serum antisperm-antibodies using an immunofluorescent technique.

AB - Serum antisperm-antibodies have been noted to develop as a result of various types of testicular pathology and injury. Their presence sometimes correlates with impaired fertility. We examined 52 patients with non-seminomatous low-stage testicular cancer for the presence of serum antisperm-antibodies to determine whether or not auto-immunity is a factor in the depressed fertility known to exist in these patients. Twenty-one per cent were discovered to have serum antisperm-antibodies using an immunofluorescent technique.

KW - antisperm-antibodies

KW - immunofluorescence

KW - testis cancer

UR - http://www.scopus.com/inward/record.url?scp=0025778324&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025778324&partnerID=8YFLogxK

M3 - Article

VL - 14

SP - 179

EP - 185

JO - International Journal of Andrology

JF - International Journal of Andrology

SN - 0105-6263

IS - 3

ER -